by McDermott + Bull | Sep 7, 2021 | Article, Ken Dropiewski
THE GREAT RESIGNATION: WHAT THE FUTURE HOLDS FOR TODAY’S JOB MARKET We hear it day in and day out — it’s so hard to find talent in this market! Oftentimes, the concept of finding “the perfect fit” stands in the way of a company making the best hiring decision, and not...
by McDermott + Bull | Aug 30, 2021 | Healthcare + Life Sciences Placement Announcement, Ken Dropiewski, Ken Dropiewski Placement Announcement, Placement Announcement
McDermott + Bull has successfully placed John Barry, Ph.D. as the Vice President of Research + Development at Miromatrix Medical, Inc. John will be responsible for the technical development of the organization’s whole organ programs and will work closely with the...
by McDermott + Bull | Aug 26, 2021 | Investor Insights, Ken Dropiewski, Video
This week, host Ken Dropiewski interviews Maria Berkman, Director, Head of MedTech at Broadview Ventures, Inc. They discuss a number of topics including investment targets, the future of MedTech, and the interview process of early-stage investors. SEE MORE INSIGHTS...
by McDermott + Bull | Jul 28, 2021 | Investor Insights, Ken Dropiewski, Video
This week, host Ken Dropiewski interviews Paul LaViolette, Managing Partner and Chief Operating Officer of SV Health Investors. They discuss a range of topics, from the timing of investments to important ideas facing the industry. SEE MORE INSIGHTS FROM TOP...
by McDermott + Bull | Jun 2, 2021 | Article, Ken Dropiewski
THE NEW NORMAL: WHAT BUSINESS TRAVEL WILL LOOK LIKE FOR EXECUTIVES Over the past six months, I’ve had the opportunity to speak with executives in the life science and medtech space about the reduction in business travel due to the pandemic. We talked about what it has...
by McDermott + Bull | May 26, 2021 | Investor Insights, Ken Dropiewski, Video
In this episode of Investor Insights, McDermott + Bull Partner Ken Dropiewski sits down with Managing Director Joe Biller of 3×5 Partners to discuss portfolio companies, investment opportunities, and new technologies in the MedTech + Life Sciences space. SEE MORE...
